Quick Answer
IGC Pharma, Inc. reported Total Revenue of $1.27 million for the year ending 2025.
- IGC Pharma, Inc. showed a decrease of -5.5% in Total Revenue from 2024 to 2025.
- This data is from IGC Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on June 27, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.13 million | Q4 2010: $484.1 thousand | Q2 2011: $1.06 million | Q3 2011: $912.1 thousand | Q4 2011: $986.8 thousand | Q2 2012: $1.27 million | Q3 2012: $1.35 million | Q4 2012: $3.93 million | Q2 2013: $1.12 million | Q3 2013: $1.13 million | Q4 2013: $17.5 thousand | Q2 2014: $763.9 thousand | Q3 2014: $2.12 million | Q4 2014: $2.54 million | Q2 2015: $1.86 million | Q3 2015: $2.06 million | Q4 2015: $1.09 million | Q2 2016: $288.5 thousand | Q3 2016: $162.2 thousand | Q4 2016: $249.8 thousand | Q2 2017: $52.9 thousand | Q3 2017: $235.0 thousand | Q4 2017: $762.0 thousand | Q2 2018: $1.48 million | Q3 2018: $811.0 thousand | Q4 2018: $1.29 million | Q2 2019: $1.65 million | Q3 2019: $1.82 million | Q4 2019: $573.0 thousand | Q2 2020: $584.0 thousand | Q3 2020: $125.0 thousand | Q4 2020: $108.0 thousand | Q2 2021: $77.0 thousand | Q3 2021: $56.0 thousand | Q4 2021: $142.0 thousand | Q2 2022: $212.0 thousand | Q3 2022: $202.0 thousand | Q4 2022: $332.0 thousand | Q2 2023: $555.0 thousand | Q3 2023: $291.0 thousand | Q4 2023: $204.0 thousand | Q2 2024: $272.0 thousand | Q3 2024: $412.0 thousand | Q4 2024: $257.0 thousand | Q2 2025: $328.0 thousand | Q3 2025: $191.0 thousand.
- Over the full 15 years of available data (2011 to 2025), IGC Pharma, Inc.'s Total Revenue has declined by 68.8%.
- Historical annual values: Fiscal year 2025: $1.27 million | Fiscal year 2024: $1.35 million | Fiscal year 2023: $911.0 thousand | Fiscal year 2022: $397.0 thousand | Fiscal year 2021: $898.0 thousand | Fiscal year 2020: $4.07 million | Fiscal year 2019: $5.12 million | Fiscal year 2018: $2.19 million | Fiscal year 2017: $580.4 thousand | Fiscal year 2016: $6.37 million | Fiscal year 2015: $7.68 million | Fiscal year 2014: $2.27 million | Fiscal year 2013: $8.03 million | Fiscal year 2012: $4.20 million | Fiscal year 2011: $4.07 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: